ફેફસાનું કેન્સર (સ્મોલ સેલ)
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
ક્યાં જવું
ભારતમાં 2 hospitals છે જે આ trial માટે patients લઈ રહ્યા છે.
રજિસ્ટ્રી સમરી (ટેકનિકલ)
This study is being done to learn more about a new medicine called PF-08634404. The study team wants to understand how well PF-08634404 works when given alone or with chemotherapy . Chemotherapy is a type of cancer treatment that uses medicines to destroy cancer cells or stop them from growing. The study is for adults with Transformed Small Cell Lung Cancer (T-SCLC ). T SCLC is a rare lung cancer that happens when one type of lung cancer changes into a more aggressive type after treatment stops working. To join the study, participants must meet the following conditions: * Are aged 18 years o…
સ્પોન્સર: ફાઇઝર
ClinicalTrials.gov પર NCT07476287
રજિસ્ટ્રીમાં છેલ્લે અપડેટ 9 ઓક્ટોબર 2026 · અમે વાંચ્યું 20 ઓક્ટોબર 2026